Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02968953|
Expanded Access Status : No longer available
First Posted : November 21, 2016
Last Update Posted : February 8, 2019
- Study Details
- Tabular View
- How to Read a Study Record
|Condition or disease||Intervention/treatment|
|Glucose Transporter 1 Deficiency Syndrome||Drug: Triheptanoin|
|Study Type :||Expanded Access|
|Expanded Access Type :||Individual Patients|
|Official Title:||Treatment With UX007 (Triheptanoin) for a Single Patient (ERS) With Glucose Transporter 1 (GLUT1) Deficiency Syndrome|
- Drug: Triheptanoin
A single patient with Glucose Transporter 1 (GLUT1) Deficiency Syndrome will receive tripheptanoin (UX007).Other Name: UX007
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||3 Years and older (Child, Adult, Older Adult)|
|Sexes Eligible for Study:||Female|
|Accepts Healthy Volunteers:||No|
- This treatment plan is intended for the use of UX007 (triheptanoin) in the treatment of a single patient with Glucose Transporter 1 (GLUT1) Deficiency Syndrome.
- Not applicable as study only includes one patient.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02968953
|United States, Pennsylvania|
|Children's Hospital of Pittsburgh of UPMC|
|Pittsburgh, Pennsylvania, United States, 15224|
|Principal Investigator:||Gerard Vockley, MD, PhD||University of Pittsburgh|
|Responsible Party:||Jerry Vockley, MD, PhD, Professor, University of Pittsburgh|
|Other Study ID Numbers:||
|First Posted:||November 21, 2016 Key Record Dates|
|Last Update Posted:||February 8, 2019|
|Last Verified:||February 2019|